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826-4 B-Type Natriuretic Peptide Levels on Admission Predict 
Short-Term Mortality and Angiographic Success of 
Procedure in Patients With Acute ST Elevation 
Myocardial Infarction Treated With Primary Angioplasty
Marcin Grabowski, Krzysztof J. Filipiak, Grzegorz Karpinski, Adam Rdzanek, Arkadiusz 
Pietrasik, Zenon Huczek, Grzegorz Horszczaruk, Janusz Kochman, Grzegorz Opolski, 
Medical University of Warsaw, Warsaw, Poland
Background: B-type natriuretic peptide (BNP) levels in the first days after the onset of
symptoms are predictive of short-term mortality in patients with acute coronary syn-
dromes. Few data are available for BNP levels obtained on admission in patients (pts)
with acute ST elevation myocardial infarction (STEMI). Methods: Blood samples for BNP
determination were obtained on admission in 117 pts (mean age 58,4±10,7 years old)
with STEMI. In a 15-minute period, BNP was measured by using simple bedside test for
rapid quantification of BNP, before primary percutaneus coronary intervention (PCI). 30
days follow-up was performed. PCI was performed in all (100%) pts. Results: Mean for
BNP was 171,8±218,2 pg/ml. Baseline level of BNP was higher among pts who died than
among those who were alive at 30 days (median, 541,9±247,2pg/ml vs. 140,9±185,9 pg/
ml; p<0,001). Baseline BNP in subgroups by median level showed a significant increase
in mortality: 1 (1%) in inframedian group (IMG) vs. 8 (13%) in supramedian group (SMG)
(p<0,05). Baseline level of BNP in subgroups by Killip class on admission was higher
among pts who died than among those who were alive at 30 days (Killip class I: median,
475,8± 280,6 pg/ml vs. 123,6±138,1 pg/ml p<0,05; Killip class II-IV: 257,1± 362,5 pg/ml
vs. 624,5± 203,9 pg/ml, p=0,01). After adjustment for independent predictors of risk of
death, the odds ratio for death at 30 days in SMG was 13,6 (95% confidence interval, 1.1
to 182.7). There was no difference in subgroups by median BNP in TIMI 3 flow grade
before PCI (7% vs. 7%; p=NS). TIMI 3 after PCI was more often seen in pts in IMG vs.
SMG (90% vs. 72%, p=0,01). BNP was higher among pts with TIMI 0, 1 or 2 after PCI
than among pts with TIMI 3 after PCI (328,3±332,8 pg/ml vs. 151,32±196,7 pg/ml;
p<0,01). BNP remained independent predictor for TIMI 0, 1 or 2 after PCI (odds ratio in
SMG was 3,5 (95% confidence interval 1,2 to 10,8). Conclusion: BNP levels obtained on
admission are powerful, independent indicator of short-term mortality and angiographic
success after PCI in pts with STEMI. Rapid tests for BNP assay seem to be new tool in
risk stratification of pts with STEMI.
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826-5 Profiling Inflammation in the Ischemic Human Heart In 
Vivo
Anders Gabrielsen, Patrick Lawler, Jesper Haeggström, Gabrielle Berne Paulsson, Wang 
Yongzhong, Daniel Steinbruchel, Jens Kastrup, Goran Hansson, Karolinska Institute, 
Stockholm, Sweden, Copenhagen University Hospital, Copenhagen, Denmark
Background: The present understanding of myocardial inflammation and its potential
role in myocardial pathophysiology is incomplete. Therefore, we used Affymetrix® Gene-
Chip analysis on normal and chronic ischemic myocardium before and during acute
ischemia and reperfusion stress to profile expression of inflammation-related transcripts.
Methods: Biopsies were sampled at baseline, after 45 min of acute total ischemia, and
after 30 min of reperfusion recovery from normally perfused and chronic reversibly
ischemic myocardium in 6 patients undergoing coronary artery by-pass grafting. RNA
was isolated, amplified with established techniques, and hybridized to HG_U133A
Affymetrix® Genechip arrays. A total of 33 arrays were performed, normalized with the
RMA algorithm, and analyzed for expression patterns of pro- and anti-inflammatory fac-
tors.
Results: At baseline, expression of 5-lipoxygenase, MCP-1 and IL-6 was higher in
chronic ischemic myocardium than in normally perfused myocardium. In response to
acute ischemia and reperfusion in the normal myocardium, there was a clear trend
towards increased expression of pro-inflammatory factors (e.g. 5-lipoxygenase, COX-2,
CysLT2 receptor, MCP-1, IL-6). These responses were less pronounced or detectably
absent in the chronic ischemic myocardium.
Conclusion: These findings suggest a discrete increase in several pro-inflammatory fac-
tors that may contribute to myocardial pathophysiology in chronic myocardial ischemia.
The blunted inflammatory response to acute ischemia in the chronic ischemic myocar-
dium may suggest altered sensitivity in signaling pathways mediating the inflammatory
response.
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826-6 Hyponatremia: A Useful Marker for Early Risk 
Assessment in Acute ST Elevation Myocardial Infarction
Alexander Goldberg, Haim Hammerman, Sirouch Petcherski, Sergey Yalonetsky, 
Alexander Zdorovyak, Michael Kapeliovich, Walter Markiewicz, Doron Aronson, Rambam 
Medical Center, Haifa, Israel, Rappaport Medical School, Haifa, Israel
Background: Hyponatremia (HNa) is common in hospitalized patients and is associated
with adverse prognosis, especially in heart failure. Data on the prevalence and prognostic
significance of HNa in the setting of acute ST-elevation myocardial infarction (STEMI) is
sparse.
Methods: We studied 1047 consecutive patients (pts) (age 60 ± 12) presenting with
STEMI. Plasma sodium concentrations (PNa) were obtained on admission and at 24-h,
48-h, and 72-h. Multiple logistic regression was performed to determine the relation
between HNa and 30-day mortality adjusting for age, sex, diabetes, hypertension, smok-
ing, Killip class, peak CK, LVEF, anterior infarction, use of diuretics and reperfusion ther-
apy.
Results: HNa (PNa < 135 mmol/L) was present on admission in 131 pts (12.5%) and
developed in 208 (19.9%) during the first 72-h. PNa decreased to <130 mmol/L in 75
(7.2%) of pts. Pts receiving diuretics developed HNa more commonly compared to pts
who were not (46% vs 28%, p< 0.0001), but the majority of hyponatremic pts (66%) were
not receiving diuretics. Kaplan-Meyer curves indicated that pts with HNa were at
increased risk of mortality (Figure). HNa on admission (OR 2.2, 95% CI 1.2-4.2, p=
0.015) and HNa developing early after admission (OR 2.7, 95% CI 1.6-4.6, p< 0.0001)
were independent predictors of 30-days mortality.
Conclusion: HNa on admission, or early development of HNa in patients with STEMI is
a strong independent predictor of 30-day mortality. PNa may serve as a simple marker to
identify patients at high risk. 
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827-2 Fasting Glucose Is an Independent Predictor of 30-Day 
Mortality in Nondiabetic Patients With Acute Myocardial 
Infarction: A Prospective Study
Mahmoud Suleiman, Walter Markiewicz, Michael Kapeliovich, Haim Hammerman, Doron 
Aronson, Rambam Medical Center, Haifa, Israel
Background: Studies have suggested that hyperglycemia may increase mortality after
acute myocardial infarction (AMI). However, these studies have not adjusted for important
determinants of prognosis and hyperglycemia was defined arbitrarily as a dichotomous
